You have 9 free searches left this month | for more free features.

Condition

Chronic Pain (1)

Moderate or Severe Opioid Use Disorder (1)

Opioid Use Disorder (1)

Opioid-use Disorder (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Braeburn Pharmaceuticals (2)

Yale University (1)

Collaborator

Alameda Health System (1)

Harvard Medical School (HMS and HSDM) (1)

Icahn School of Medicine at Mount Sinai (1)

NYU Langone Health (1)

National Drug Abuse Treatment Clinical Trials Network (1)

The Emmes Company, LLC (1)

University of Pennsylvania (1)

Weill Medical College of Cornell University (1)

Intervention

cam2038 (3)

buprenorphine sublingual product (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

cam2038

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Opioid Use Disorder, Chronic Pain Trial in Birmingham, Berlin, Oklahoma City (CAM2038)

Completed

Has Results

Opioid Use Disorder
Chronic Pain

CAM2038

Birmingham, Alabama
+2 more

Apr 29, 2020

Moderate or Severe Opioid Use Disorder Trial in Overland Park, Lexington, New York (CAM2038)

Completed

Has Results

Moderate or Severe Opioid Use Disorder

CAM2038

Overland Park, Kansas
+2 more

Nov 11, 2019

Opioid-use Disorder Trial in United States (CAM2038, Buprenorphine Sublingual Product)

Recruiting

Opioid-use Disorder

CAM2038
Buprenorphine Sublingual Product

Phoenix, Arizona
+34 more

Aug 31, 2021